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One of the most unique viral replication schemes is 
that of the retroviruses (a class that includes the RNA 
tumor viruses). These viruses synthesize a double- 
stranded (DS) DNA copy of their single-stranded (SS) 
RNA genome as the initial event following infection of 
susceptible cells (see Weinberg 1977). The details of 
this process--called reverse transcription--are still 
obscure, but the general outlines have become clear 
during the last few years. 
The study of reverse transcription has proceeded 
along two lines. Some workers have studied nucleic 
acid molecules extracted from recently infected cells 
(Weinberg 1977); others have utilized in vitro systems 
of reverse transcription either with detergent-activated 
virions or in reconstructed systems (Verma 1977; 
Taylor 1977). Although the in vitro systems have been 
useful in studying individual events of the reverse 
transcription process, only recently have the systems 
been perfected to the point where they mimic in vivo 
results. 
This paper is concerned with the proof that in vitro 
systems derived from detergent-activated virions of 
murine leukemia virus (MuLV) do mimic quite faith- 
fully the events that occur in infected cells. We also 
describe an unexpected effect of actinomycin D (Act 
D) on the reverse transcription process and will inter- 
pret that effect in the context of a general model of the 
process of reverse transcription. 
In Vivo Reverse Transcription 
The retrovirus genome is a dimer of two 35S 
molecules (Bender et al. 1978), but because the di- 
meric structure does not enter the reverse transcrip- 
tion process in any known way, we can treat the 
molecule as if it were a single plus-strand RNA about 
9000 nucleotides long. 
After a retrovirus infects a cell, the plus-strand RNA 
is used as a template by the virion-associated reverse 
transcriptase for synthesis of minus-strand DNA. Syn- 
thesis of full-length minus strands requires a few hours, 
but before completion of the minus strand, plus-strand 
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DNA begins to become vident (Varmus et al. 1978). A 
major early component of plus-strand DNA is a discrete 
molecule a few hundred nucleotides long that is initiated 
somewhere near the 5' end of the minus-strand DNA 
and represents a copy of the 5' end of the DNA. The final 
product of reverse transcription i cludes molecules with 
full-length minus strands and with partial pieces of 
plus-strand DNA. Later in infection, closed circular DS 
DNA becomes evident (for a more complete discussion, 
see Weinberg [1977]). 
Reverse Transcription In Vitro 
Until recently, only the early stages of reverse 
transcription could be studied in in vitro reactions, 
because reproducible extensive synthesis of long 
cDNA could not be achieved (Temin and Baltimore 
1972). The early events of reverse transcription, how- 
ever, have proved fascinating. The primer for minus- 
strand DNA synthesis has been identified as a specific 
tRNA hydrogen-bonded to the virion RNA at a 
position about 100 nucleotides from the 5' end (Taylor 
1977). The early product of reverse transcription is 
therefore a DNA molecule, called strong-stop DNA, 
that extends about 100 nucleotides towards the 5' end 
of the RNA genome and then stops its synthesis 
abruptly because i t  runs out of template (Haseltine t 
al. 1976). An exact repetition of base sequence at the 
5' end and the 3' end of the genome allows DNA 
synthesis to be reinitiated by hybridization of the 3' 
end of strong-stop DNA to a position just following 
the poly(A) of the 3' end of the viral RNA (see 
Haseltine and Coffin, this volume). Synthesis of DNA 
then picks up again, and an extensive copy of the 
majority of viral RNA is made. 
To study events further, it was necessary to optimize 
the reverse transcription system for the synthesis of 
minus-strand DNA. In the case of MuLV, it was 
shown that a combination of a relatively high concen- 
tration of deoxyribonucleoside triphosphates (dNTPs), 
a concentration of magnesium just less than the sum of 
the triphosphate concentration, and a minimal salt 
concentration would allow synthesis of the longest 
possible DNA molecules in reactions that continued 
over at least 10 hours (Rothenberg and Baltimore 
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1976, 1977; Rothenberg et al. 1977). Although the 
products span a range of sizes, two discrete minus- 
strand DNAs are made that are approximately the size 
of the viral RNA. The longer of these two DNA 
species (8.8-kb DNA) is made in reverse transcription 
reactions that lack Act D. The second, smaller species 
(8.2-kb DNA) is made both in the presence and in the 
absence of Act D (Rothenberg et al. 1977). 
To understand the effect of Act D, it is important to 
know whether the 8.2-kb and 8.8-kb DNAs differ from 
each other at their 3' ends or their 5' ends. It has been 
possible to show that the difference lies at the 3' end of 
the molecule (this being the equivalent of the 5' end of 
viral RNA). This was demonstrated by forming 
heteroduplex molecules between the 8.2-kb and 8.8-kb 
DNAs and the mRNA responsible for the synthesis of 
the envelope glycoprotein of the MuLV (Rothenberg 
et al. 1978). This mRNA is a composite, or spliced, 
molecule, which obtains its leader sequence from the 
5' end of the genome RNA and a majority of its 
sequence from the 3' end of the viral genome. It was 
found that 8.2-kb DNA could hybridize to both parts 
of the molecule, implying that 8.2-kb DNA extends 
into the leader sequence. The 8.2-kb DNA, however, 
did not completely cover the leader sequence. In 
contrast, the 8.8-kb DNA completely covered the 
leader sequence and possibly extended beyond it. This 
result maps the extra 600 bases on 8.8-kb DNA to the 
3' end of the minus-strand DNA molecule and 
implies that Act D can prevent the addition of the 
final 600 bases to 8.8-kb DNA. 
To understand reverse transcription, we must then 
understand why Act D inhibits the synthesis of the 
longer DNA. Although it is possible that Act D could 
have a variety of effects, it is a very likely that it acts 
by inhibiting DNA-dependent DNA synthesis rather 
than RNA-dependent DNA synthesis (Kahan et al. 
1963). Thus, the last 600 nucleotides of 8.8-kb minus- 
strand DNA would, by this reasoning, result from the 
copying of DNA rather than RNA. Act D is already 
known to have one major effect on the reverse tran- 
scription process: it prevents synthesis of any plus- 
strand DNA because plus-strand DNA synthesis is a 
DNA-dependent process (Manly et al. 1971). An at- 
tractive hypothesis is, therefore, that the final 600 
nucleotides of 8.8-kb DNA are synthesized as a copy 
of plus-strand DNA rather than as a copy of viral 
RNA. We shall return to this point in the final section 
of this paper. 
Synthesis of Infective DNA 
To prove that the "optimal" conditions for reverse 
transcription can reasonably mimic events in vivo, we 
have investigated the infectivity of the DNA made in 
vitro. It was found that after 4 hours of reaction, 
infective DNA molecules became evident in the reac- 
tion mixture, and their concentration increased con- 
tinually for at least 6 more hours of reaction (Rothen- 
berg et al. 1977). Act D, not surprisingly, prevented 
the synthesis of infective DNA molecules. 
More recently, we have found that the infective 
DNA molecules are resistant o digestion with the 
single-strand-specific St nuclease (Table 1). This im- 
plies that the infective DNA represents full-length DS 
DNA molecules, a result that is consistent with the 
previous demonstration that the majority of the 
infectious molecules sediment like full-length DS 
DNA (Rothenberg et al. 1977). 
To examine the DS DNA molecules made during 
reverse transcription, a preparation of DNA made in 
vitro was analyzed by neutral agarose gel elec- 
trophoresis. A band of DNA of approximately 9000 
bp (base pairs) was evident among the products; also 
evident was a very heterogeneous collection of other 
molecules (Fig. 1, lane a). Treatment of the reverse 
transcription product with ribonuclease at either high 
or low salt helped to clear up the heterogeneous 
background (Fig. 1, lanes c and e); more importantly, 
however, treatment of the product with $1 nuclease-- 
with or without ribonuclease--resolved a quite discrete 
band of 9000-bp DNA (Fig. 1, lanes b, d, and f). 
When Sl-nuclease digest products were separated by 
agarose gel electrophoresis and the individual bands 
were cut out and tested for their infectivity, it was 
found that at least 80% of the infectivity resided in the 
9000-bp DNA. Figure 2 shows the DNA that was 
analyzed and Table 2 demonstrates that the infectivity 
was found mainly in band B, the 9000-bp DNA. In both 
Figures 1 and 2, a faint band (A) larger than the 9000-bp 
DNA is also evident. Preliminary evidence suggests that 
this is a circularized form of the 9000-bp DNA (E. 
Gilboa and D. Baltimore, unpubl.). 
To study the 9000-bp DNA further, it was compared 
to the DS DNA made in vivo. This DNA was detec- 
ed by the Southern (1975) blotting procedure. In vitro 
and in vivo products had identical electrophoretic 
mobilities. Using a series of restriction endonucleases, 
we compared these products in greater detail. An 
exact correspondence of bands was observed (Fig. 3), 
although a few extra bands were found in the in vitro 
product. (These extra bands appear to have their 
origin in circular molecules that are presently under 
investigation.) A map of these fragments based on the 
analysis of Yoshimura et al. (1979) and Verma and 
McKennett (1978) is shown in Figure 4. It is evident 
that both the 5'-end and 3'-end fragments of the DNA 
are represented among the restriction fragments that 
Table 1. Effect of Sl-nuclease Digestion on the Infectivity of 
DNA Synthesized in Purified Virions 
Sa-nuclease tr atment DNA (/.tg) Plaques 
- 0.45 23 
- 0.90 45 
+ 0.45 23 
+ 0.90 36 
DNA was synthesized in purified virions and digested with RNase 
A. Half of the DNA preparation was subsequently digested with Sl 
nuclease. Infectivity ofDNA was tested by transfecting NIH/3T3 ceils 
as described by Rothenberg el aL (t977). 
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Figure 1. Analysis of DNA synthesized invirions of purified 
MnLV by electrophoresis through neutral agarose gels. DNA 
was synthesized in the endogenous reaction as described by 
Rothenberg et al. (1977) in the presence of [a-32P]dCTP. The 
incubated reaction mixture was digested with 0.2 mg/ml pro- 
teinase K in the presence of 0.5% SDS for 30 min at 37~ 
phenol extracted, precipitated with ethanol, and dissolved in 
10 mM Tris (pH 7.5), and the material excluded by Sephadex 
G-50 was taken. Portions containing 1.0-1.5 x 104 cpm were 
digested with 10 t~g/ml RNase A in 10 mi  Tris (pH 7.5), 
1 mi  EDTA without (low salt) or with (high salt) 300 mM 
NaC1, as indicated, for 60min at 37~ The products were 
extracted with phenol andprecipitated with ethanol. Subse- 
quent Sl nuclease digestion (+)was performed in 30mM 
sodium acetate (pH 4.5), 300 mi  NaCI, 5 mM ZnC12 in the 
presence of 2/.,g of salmon sperm SS DNA for 60 rain at 
45~ Samples were extracted with phenol, precipitated with 
ethanol, dissolved in 40mM Tris-acetate (pH 8.3), 1 mM 
EDTA, 5% glycerol and 0.05% bromphenol blue (BPB), and 
subjected to electrophoresis in 1% agarose in 40rnM Tris- 
acetate (pH 8.3), 1 mM EDTA for 18 hr at 2 V/hr. Gels were 
dried and DNA was detected by autoradiography. (a) Un-
treated DNA; (b) DNA digested with $1nuclease; (c) DNA 
digested with RNase in the absence of NaCI; (d) DNA 
digested with RNase in the absence of NaCI and subse- 
quently digested with $1 nuclease; (e) DNA digested with 
RNase in 300mM NaC1; (f) DNA digested with RNase in 
300 mM NaCI and subsequently digested with $1 nuclease. 
are present in both the in vivo DNA and the in vitro 
DNA. 
To study the SS DNA components of the 9000-bp 
DNA, it was purified and denatured. Figure 5 compares 
the pure 9000-bp DNA with a total $1 nuclease digest of 
the reverse transcription product. After denaturation 
and analysis by electrophoresis through alkaline g ls, 
one band was recovered from the 9000-bp DNA (lane c) 
that comigrated with the larger 8.8-kb band from the 
total product (lane d). The major band from the total 
DNA, the 8.2-kb DNA, was not found in the 9000-bp 
product. 
(-) 
--A 
e - -B  --C 
--D 
--E 
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l~gure 2. Preparative fractionation of DNA synthesized in 
purified virions. DNA was synthesized and fractionated on 
1% agarose gels as described in the legend to Fig. 1. DNA 
from regions A-E  was excised and the agarose slice was 
dissolved in saturated KI containing 10tzg salmon sperm 
DNA as carrier, passed through 0.5ml hydroxylapatite at
60~ and washed with 10 mM sodium phosphate (pH 6.8) and 
100 mM NaCI. The bound DNA was eluted with 0.5 M sodium 
phosphate (pH 6.8), passed through Sephadex G-50, precipi- 
tated with ethanol, and used in the experiment described in 
Table 2. 
These data demonstrate hat only the 8.8-kb DNA 
is present in the 9000-bp DNA. We presume that this 
8.8-kb DNA is the minus strand of DNA, although that 
has yet to be directly demonstrated, and we are 
uncertain whether the plus strand of DNA is to be 
found as full-length material or as a broadly 
heterogeneous collection of molecules that are not 
evident in Figure 5 (lane c). The 8.2-kb DNA appears 
to be largely removed by the Sl-nuclease treatment, 
implying that most of it contains ingle-strand regions. 
It therefore appears likely that the generation of 
full-length DS DNA is coupled to the synthesis of 
8.8-kb DNA and that 8.2-kb DNA can not become 
converted into fully DS DNA molecules. 
Summary and Model 
We have shown that under the appropriate condi- 
tions of reverse transcription, detergent-activated vi- 
Table 2. Transfection of NIH/3T3 Cells with DNA Fractions 
Synthesized in Purified Virions 
DNA tested Total initial 
DNA fraction (/zg) Plaques infectivity (%) 
Total Sl-treated DNA 0.8 17 
1.6 41 (100) 
Band A 0.024 2 5 
Band B 0.023 7 
0.046 16 81 
Band C 0.011 0 0 
0.022 0 0 
Band D 0.038 0 0 
Band E 0.099 0 0 
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Figure 3. Digestion with restriction enzymes of the in vitro synthesized 9000-bp DNA and the linear form of viral DNA isolated 
from acutely infected cells. DNA synthesized with [ot-3~p]dCTP in purified virions was prepared as described n the legend to 
Fig. 1 and the 9000-bp DNA molecule was purified as described in the legend to Fig. 2. The linear form of viral DNA was isolated 
from acutely infected cells according to the method of Hirt (1967), followed by equilibrium centrifugation in CsCI to remove 
circular forms and velocity sedimentation in a sucrose gradient (Gianni et al. 1975). Samples were digested with various 
restriction enzymes and subjected to electrophoresis on 2% neutral agarose gels. The digestion products of in vitro synthesized 
9000-bp DNA were detected byautoradiography and the restriction fragments derived from the in vivo linear form of viral DNA 
were detected bythe Southern (1975) blotting technique following hybridization with a 3~P-labeled 35S-virion RNA probe. The 
numbers indicate the approximate length of the fragments (in bp) as estimated from the migration of a Si ai digest of Ad5 DNA 
(not shown). A and B are two separate gels. 
rions will synthesize DS DNA molecules that ppear 
indistinguishable from the linear DS DNA molecules 
that occur in infected cells. Act D has two effects on 
this process: it prevents the synthesis of any plus- 
strand DNA and it prevents the completion of the 3' 
end of limit-length minus-strand DNA. There is a 
model that rationalizes the behavior of this system. 
The model is derived from the data presented here, 
from results of earlier experiments performed in our 
laboratory (Rothenberg et al. 1977, 1978), and from 
the evidence presented by Taylor et al. and by Varmus 
et al. (both this volume). Taylor et al. and Varmus et 
al. have shown that the linear, circular, and integrated 
forms of viral DNA contain a terminal direct repeat 
that is approximately the length that we find lacking in 
DNA made in the presence of Act D. We have been 
able to confirm their results by showing that restriction 
enzymes that cut the full-length DNA within a few 
hundred nucleotides from one end also cut the DNA 
near the other end 0E. Gilboa and D. Baltimore, 
unpubl.). This is consistent with the idea that the last 
600 or so nucleotides of the 9000-bp DNA represent a 
linear extension f the DNA beyond the 5' end of the 
RNA. The sequences represented by this extension 
would appear to derive from a recopying of the 3' end 
of the genome (Taylor et al.; Varmus et al.; both this 
volume). 
The model that integrates all of these data is shown in 
Figure 6. For ease of presentation, we have shown the 
viral RNA as a circular molecule, but we do not mean 
to imply that the 3' end and 5' end are physically 
/inked. The first part of the model is similar to that 
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Figure 4. Restriction endonuclease maps of the 
full-length, linear, unintegrated Moloney 
murine leukemia proviral DNA. The restriction 
endonuclease maps were constructed by 
Yoshimura et al. (1978) for BamHI, Sinai, and 
PstI and by Verma and McKennett (1978) for 
BamHI and HpaI. 
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Figure 5. Strand composition of the 9000-bp DNA. DNA was 
synthesized asdescribed inthe legend to Fig. 1 and the 9000-bp 
DNA was isolated as described in the legend to Fig. 2. (a) 
Purified 9000-bp DNA analyzed on a nondenaturing 1% 
agarose gel; (b) total unfractionated, S]-nuclease-digested 
DNA analyzed for comparison; (c) purified 9000-bp DNA 
analyzed under denaturing conditions (30 mM NaOH) in a I% 
agarose gel; (d) total unfractionated DNA analyzed in 30 mM 
NaOH for comparison. 
presented previously by Haseltine and Baltimore 
(1976) and Haseltine et al. (this volume) and shows 
DNA synthesis initiated on a tRNA near the 5' end of 
the viral RNA and then jumping to the 3' end of viral 
RNA, where synthesis is reinitiated and continues 
around the RNA. After a certain amount of minus- 
strand synthesis has occurred, plus-strand synthesis 
is initiated as implied by the work of Varmus et al. 
(1978 and this volume). Their work suggests that 
there is a specific site for initiation, although it is 
unclear what controls initiation at that site. A piece of 
plus-strand DNA is then made that extends about 
600 nucleotides towards the 3' end of the RNA. In the 
presence of Act D, this synthesis does not occur, and 
the synthesis of minus-strand DNA stops somewhat 
short of the end of the RNA. What prevents ynthesis 
at that point is obscure. 
In the absence of Act D, synthesis i  also blocked at 
that point, but by a mechanism that may be analogous 
to the original jump that starts minus-strand syn- 
thesis, DNA synthesis jumps to the fragment of plus- 
strand DNA; the final copying of the minus-strand 
DNA is actually DNA-dependent DNA synthesis. In 
this way, we account for the Act-D sensitivity of the 
addition of the final 600 nucleotides to the minus 
strand. The minus strand generated in this way will 
have at its 3' end an exact repeat of about 600 
nucleotides of the sequence at its 5' end. The sequence 
homology that enables the minus trand to jump to 
the plus-strand fragment presumably lies in the 
tRNA-binding site or in strong-stop DNA, but the 
exact extent of this homology requires further investi- 
gation. 
8.8kb 
< (-)DNA 
1 
(+)DNA 
90kbp 
Figure 6. A model of reverse transcription. The model shows 
the initial production of strong-stop minus-strand DNA 
attached to he tRNA primer. After this DNA jumps to the 
3' end of the RNA, a long minus-strand DNA is made that 
terminates just short of the 5' end of the RNA genome. In the 
presence of Act D, minus-strand DNA synthesis terminates 
(8.2-kb DNA), but in the absence of the drug, a short piece of
plus-strand DNA is made as a copy of the 5' end of the 
minus-strand DNA. Synthesis of minus-strand DNA by jump- 
ing to the short plus-strand DNA and copying it. This jump 
positions the plus-strand DNA so that it can continue synthesis 
by copying the minus-strand DNA. The end result is the 
9000-bp DS DNA. 
Once DNA synthesis has jumped to the plus 
strand, we can then imagine plus-strand synthesis 
continuing with the initial piece of plus-strand DNA 
acting as primer. Elongation could then occur all the 
way to the other end of the minus-strand DNA. The 
extensive evidence, however, showing that plus- 
strand DNA is in fragments (see Weinberg 1977; 
Varmus et al. 1978) implies that there are other 
starting points along the minus strand for plus- 
strand synthesis and that ultimately the plus strand 
may be put together by the ligation of fragments. In 
any case, the second jump positions the primer for the 
plus strand at the exact end of the molecule and 
means that the ultimate product of reverse transcrip- 
tion can be completely double-stranded. In this way, 
we account for the fact that the infectious DNA 
molecules made in vitro show no S~ nuclease sensitiv- 
ity (Table 1), implying that they do not have any single 
strands at either end and that the priming mechanism 
for the synthesis of both strands must be able to leave 
flush ends at the two termini (unless, of course, there 
is a sequence at either end that is unnecessary for the 
infectivity of the molecule). 
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Although this model is somewhat speculative and 
incomplete, we believe that its major elements are 
probably an appropriate representation of how reverse 
transcription occurs. 
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